Tomyam fried rice cause of 43 students food poisoning
TELUK INTAN: Tomyam fried rice is suspected to be the cause of a food poisoning incident involving 43 students from Sekolah Menengah San Min on Jalan Sungai Nibong here last month.
Perak Human Resources, Health, Indian Community Affairs and National Integration Committee chairman, A. Sivanesan, said the infection source is believed to be food prepared by the school canteen on April 21.
He said the food poisoning case was first detected when two students showed symptoms on April 22, followed by an official notification to the Hilir Perak District Health Office (PKD) two days later.
'All affected students, aged between 13 and 18, experienced symptoms such as stomach pain, diarrhoea, vomiting and fever. They received outpatient treatment and are in stable condition.
'Two clinical samples tested positive for norovirus and sapovirus infections. The PKD is conducting further investigations to determine the exact source of the infections and any contributing factors,' he told a press conference after visiting the school today.
Sivanesan said the PKD's hygiene inspection of the school's canteen found the cleanliness level unsatisfactory.
He said a four-day closure order was issued under Section 18(1)(f) of the Prevention and Control of Infectious Diseases Act 1988 [Act 342], effective immediately.
'The canteen operator has taken corrective actions as instructed, and after a re-evaluation, the premises were allowed to resume operations,' he said.
Sivanesan said the Perak Health Department will continue to monitor the situation and work with all relevant parties to ensure that students' health and food safety are consistently safeguarded.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Malay Mail
17 hours ago
- Malay Mail
Bensang Pharmaceuticals Officially Enters Japanese Duty-Free Market, Opening a New Chapter in Health Consumption
TOKYO, JAPAN - Media OutReach Newswire - 3 June 2025 - Bensang Pharmaceuticals (China), a leading health and wellness brand, announced today that its full product line has officially entered Tokyo duty-free stores, marking a deep collaboration in the health consumption sector. This partnership not only provides consumers with a global authentic purchasing channel but also integrates high-quality health products with the premium duty-free shopping Duty Free is a world-leading travel retail platform with a global supply chain network and millions of passenger flows, serving as a key gateway for premium brands entering international markets. Bensang Pharmaceuticals, with its scientific formulations, stringent quality control, and diverse product portfolio, has earned strong market recognition. The brand will set up exclusive display zones in duty-free stores and launch limited-time promotional offers to meet the diverse health product demands of both international travelers and local growing health awareness, wellness products have become a new growth driver in duty-free consumption. Bensang's commitment to R&D and product innovation aligns perfectly with Tokyo Duty Free's positioning as the "preferred destination for quality living."As China's health industry continues to expand, its market size is projected to exceed ¥20 trillion by 2025. Duty-free channels, with their "authenticity guarantee + competitive pricing," have become the top choice for high-net-worth individuals and cross-border shoppers. Bensang's entry into duty-free stores is a crucial step in its globalization strategy, driving the Chinese health supplement industry toward premium and international #BensangPharmaceuticals The issuer is solely responsible for the content of this announcement. About Bensang Pharmaceuticals Bensang Pharmaceuticals is dedicated to the R&D and production of high-quality health products, including dietary supplements, pharmaceuticals, and medical devices. The company aims to advance global health industry development and help people achieve a better quality of life.
The Star
20 hours ago
- The Star
17 medical devices that failed tests not safe to be uses, says MDA
PUTRAJAYA: The Medical Device Authority (MDA) confirms that the 17 types of medical devices sold online, which previously failed safety tests, are now safe for use by the public. MDA chief executive Dr Muralitharan Paramasua said that based on a review of the investigation report and re-testing submitted, it has found that all the medical devices now meet the standards and are safe and effective for continued use by the public. The affected devices are Dynmed brand oxygen concentrators; Angel Biss (SH01) and Carer; blood pressure monitors (BPLife, Novoplus, Yuwell and Ouson+); glucose meters (Roche, Sinocare and Yasee); thermometers (BioCare, Scaneo dan Ouson+) as well as surgical and examination gloves (Gammex, Shirudo, Puritex and Infinity Latex). Dr Muralitharan said that thorough investigations and corrective actions had been carried out by all the companies following the Feb 15 MDA report regarding the devices' failure to comply with standards. "All the establishments involved showed a high commitment to undergoing full investigations. This is in line with the post-market responsibilities outlined in the Medical Device Act 2012 (Act 737)," he said in a statement Tuesday (June 3). Dr Muralitharan said comprehensive actions, such as the improvements in quality control systems, compliance with regulation guidelines as well as increased transparency in managing safety and efficacy issues of the devices had helped restore public confidence. He also advised the public to be more cautious when purchasing medical devices online. "The public needs to ensure the medical devices bought are registered with the MDA and sold by licensed establishments," he said. Further information and complaint channels can be accessed via official MDA website at or by contacting 03-8230 0300. - Bernama
New Straits Times
2 days ago
- New Straits Times
Vape device interim licence issued by Miti
KUALA LUMPUR: The Health Ministry has clarified that a recent interim licence for manufacturing nicotine-based vape devices was issued by the Investment, Trade and Industry Ministry (Miti). The licence was granted through the Malaysian Investment Development Authority (Mida) under the Industrial Coordination Act 1975 and local licensing laws. This comes after media reports said a Nasdaq-listed company from the United States had received Malaysia's first federal licence to produce nicotine products. The Health Ministry explained that while Miti issues manufacturing licences, the production, import, and sale of nicotine liquids are regulated under the Control of Smoking Products for Public Health Act 2024 (Act 852). Section 2 of the Act defines nicotine liquids—including substances like nicotine, propylene glycol, glycerol, and triethylene glycol—as smoking products. These products can be sold in Malaysia, but they are strictly regulated. The ministry said it is responsible for monitoring the contents and emissions of these products to protect public health. "The regulation of these smoking products also involves other government agencies, including an import control by the Customs Department through restrictions covering raw materials and finished goods under the Customs (Prohibition of Imports) Order 2008. "Among others, device safety standard testing by Sirim, enforced under the Trade Descriptions (Certification and Marking) of Electronic Cigarette Devices (Vape Device) Order 2022 under the Trade Descriptions Act 2011, under the purview of the Domestic Trade and Cost of Living Ministry," the statement read. The Health Ministry stressed that all decisions on vape liquid production and sales are made jointly by relevant authorities and reaffirmed its commitment to strong enforcement and public health safety.
